Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition applied to pediatric clinic for treating bedsore

A technology for clinical use and composition, applied in the field of pharmaceutical composition for the treatment of decubitus clinically in pediatrics, can solve the problems of toxic heat symptoms, inability to remove toxic heat symptoms and infection, easy to be exposed to toxins, etc., achieve significant curative effect, promote Shedding and sore healing, medicinal property exerts good effect

Inactive Publication Date: 2017-05-17
王爱荣
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the seepage of fat and water on the surface of sores, which consumes qi and blood, it is generally a deficiency syndrome. Among the medicines, the symptoms of toxic fever and infection cannot be removed, which brings pain to children

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A pharmaceutical composition for treating bedsores for pediatric clinical use, its components include by weight: 5 parts of keel, 6 parts of red bone ginseng, 5 parts of rhubarb, 3 parts of Tongcao, 3.5 parts of Panax notoginseng, 3 parts of Puxiao, and 50 parts of sesame oil 7 parts of metronidazole, 4 parts of angelica, 4 parts of coptis, 3.5 parts of raw land, 1.5 parts of scorpion, 1.5 parts of centipede, 1.5 parts of borneol, 6 parts of cinnabar, 5 parts of myrrh, 8 parts of calamus, and 9 parts of cattail 8 parts of white root, 6 parts of galangal, 3 parts of kudzu root, 2 parts of Sichuan achyranthes bidentata, 3 parts of frankincense, 7 parts of mistletoe, 5 parts of chrysanthemum, 4 parts of windproof, 4 parts of turmeric, 2.5 parts of ground bone skin , 11 parts of beeswax, 6 parts of drynaria, 6.5 parts of elm bark.

Embodiment 2

[0017] A pharmaceutical composition for pediatric clinical treatment of decubitus, its components include by weight: 6 parts of keel, 7 parts of red bone ginseng, 7 parts of rhubarb, 4.5 parts of Tongcao, 5 parts of Panax notoginseng, 3.5 parts of Puxiao, 80 parts of sesame oil 10 parts of metronidazole, 7 parts of angelica, 6 parts of coptis, 5.5 parts of raw land, 3.5 parts of scorpion, 2.2 parts of centipede, 2.5 parts of borneol, 8 parts of cinnabar, 7 parts of myrrh, 11 parts of calamus, and 11 parts of cattail 11 parts of white root, 8 parts of galangal, 6 parts of kudzu root, 6 parts of Sichuan achyranthes bidentata, 7 parts of frankincense, 10 parts of mistletoe, 8 parts of chrysanthemum, 6 parts of Fangfeng, 5 parts of turmeric, 5 parts of Digupi , 15 parts of beeswax, 8 parts of drynaria and 8 parts of elm bark.

Embodiment 3

[0019] A pharmaceutical composition for pediatric clinical treatment of decubitus, its components include by weight: 8 parts of keel, 8 parts of red bone ginseng, 8 parts of rhubarb, 5 parts of Tongcao, 8 parts of Panax notoginseng, 6 parts of Puxiao, and 120 parts of sesame oil 12 parts of metronidazole, 12 parts of angelica, 7 parts of berberine, 5 parts of raw land, 5 parts of scorpion, 3.5 parts of centipede, 3.5 parts of borneol, 12 parts of cinnabar, 8 parts of myrrh, 12 parts of calamus, and 12 parts of cattail 12 parts of white root, 8 parts of galangal, 6 parts of kudzu root, 7 parts of Sichuan achyranthes, 12 parts of frankincense, 15 parts of mistletoe, 12 parts of chrysanthemum, 9 parts of windproof, 6 parts of turmeric, 6 parts of digupi , 18 parts of beeswax, 12 parts of drynaria, 12 parts of elm bark.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition applied to pediatric clinic for treating bedsore. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 5-12 parts of ossa draconis, 5-12 parts of salvia chinensis, 5-12 parts of radix et rhizoma rhei, 2-8 parts of tetrapanax papyriferus, 3-12 parts of radix notoginseng, 2-9 parts of impure mirabilite, 50-130 parts of sesame oil, 7-15 parts of metronidazole, 3-15 parts of radix angelicae sinensis, 3-10 parts of rhizoma coptidis, 3-8 parts of unprocessed rehmannia roots, 1-7 parts of scorpion, 1-5 parts of scolopendra, 1-5 parts of borneol, 6-15 parts of cinnabaris and 5-12 parts of myrrh. The pharmaceutical composition has the functions of drawing out toxins, removing pus, resisting slough, invigorating circulation of blood, relieving pain, rapidly diminishing swelling, rapidly promoting granulation and diminishing inflammation, rapidly controlling infection after the pharmaceutical composition is used, is obvious in clinical application curative effect and excellent in exertion of medicine effect, and is economical and practical; after external application of the pharmaceutical composition, the pharmaceutical composition can achieve effects of promoting blood circulation, relieving pain, eliminating necrotic tissues and promoting granulation, accelerating falling of necrotic tissue and healing of wounds; in the using process, the pharmaceutical composition is convenient to use, produce and store.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for pediatric clinical treatment of bedsores. Background technique [0002] Pressure sores, also known as pressure ulcers or decubitus ulcers, are due to long-term pressure on local tissues, resulting in continuous ischemia, hypoxia, and malnutrition, resulting in tissue ulceration and necrosis. Skin pressure sores are a common problem in rehabilitation and nursing care. According to relevant literature reports, about 60,000 people die of pressure ulcer complications every year. [0003] Bed sores are caused by long-term bed rest, partial pressure, blockage of meridians, stagnation of Qi and blood, loss of nourishment of the skin, and even tissue necrosis and decay. Due to the seepage of fat and water on the surface of sores, which consumes qi and blood, it is generally a deficiency syndrome. Among the traditional medicines, t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P17/02A61K35/644A61K33/30A61K35/646A61K35/648A61K31/045A61K33/28A61K31/4164A61K33/04A61K35/02
CPCA61K35/02A61K31/045A61K31/4164A61K33/04A61K33/28A61K33/30A61K35/644A61K35/646A61K35/648A61K36/126A61K36/185A61K36/21A61K36/232A61K36/238A61K36/25A61K36/258A61K36/31A61K36/324A61K36/328A61K36/488A61K36/537A61K36/708A61K36/718A61K36/804A61K36/815A61K36/88A61K36/896A61K36/898A61K36/9062A61K36/9066A61K2300/00
Inventor 王爱荣
Owner 王爱荣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com